superior results than 24 wk data this is huge

  1. 27,629 Posts.
    lightbulb Created with Sketch. 399
    Fantastic.

    Avexa Reports Superior Results in ATC Phase IIb Clinical Trial Update.

    48 week data shows 90% of treated patients achieve undetectable viral loads

    Key Highlights from the 48 week data.

    • Increase in the percentage of patients with viral loads below detectable at week 48 compared to week
    24
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.